Literature DB >> 17251235

Talc mediates angiostasis in malignant pleural effusions via endostatin induction.

N Nasreen1, N Najmunnisa, K A Mohammed, S Brown, Y Su, P S Sriram, B Moudgil, R Loddenkemper, V B Antony.   

Abstract

Talc remains the most effective sclerosing agent for pleurodesis. However, its mechanism of action in resolving pleural malignant disease remains unclear. The present study evaluated the angiogenic balance in the pleural space in patients with malignant pleural effusions (MPE) following talc insufflation. Patient pleural fluid samples were collected both before and after talc insufflation. The ability of pleural mesothelial cells (PMC) and malignant mesothelioma cells (MMC) to produce endostatin in vitro was compared. The biological effects of pleural fluids and conditioned media from talc-activated PMC on endothelial cells were evaluated by performing proliferation, invasion, tube formation and apoptosis assays. Pleural fluids from patients with MPE who received thoracoscopic talc insufflation contained significantly higher levels of endostatin (median 16.75 ng.mL(-1)) compared with pre-talc instillation (1.06 ng.mL(-1)). Talc-activated PMC released significantly greater amounts of endostatin (mean+/-SEM 1052.39+/-38.66 pg.mL(-1)) when compared with a MMC line (134.73+/-8.72 pg.mL(-1)). In conclusion, talc alters the angiogenic balance in the pleural space from a biologically active and angiogenic environment to an angiostatic milieu. Functional improvement following talc poudrage in patients with malignant pleural effusions may, in part, reflect these alterations in the pleural space.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251235     DOI: 10.1183/09031936.00061606

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

Review 1.  From "awake" to "monitored anesthesia care" thoracic surgery: A 15 year evolution.

Authors:  Tommaso C Mineo; Federico Tacconi
Journal:  Thorac Cancer       Date:  2014-01-02       Impact factor: 3.500

Review 2.  Switching off malignant pleural effusion formation-fantasy or future?

Authors:  Magda Spella; Anastasios D Giannou; Georgios T Stathopoulos
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

3.  Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.

Authors:  Marta Korsic; Sonja Badovinac; Branka Cucevic; Zoran Janevski
Journal:  Wien Klin Wochenschr       Date:  2015-04-10       Impact factor: 1.704

Review 4.  Malignant pleural effusion: tumor-host interactions unleashed.

Authors:  Georgios T Stathopoulos; Ioannis Kalomenidis
Journal:  Am J Respir Crit Care Med       Date:  2012-05-31       Impact factor: 21.405

Review 5.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

6.  The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications.

Authors:  Foteini Economidou; George Margaritopoulos; Katerina M Antoniou; Nikolaos M Siafakas
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

7.  Role of talc modulation on cytokine activation in cancer patients undergoing pleurodesis.

Authors:  Yehuda Schwarz; Alex Star
Journal:  Pulm Med       Date:  2012-03-07

8.  Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.

Authors:  Li-Han Hsu; Pei-Chi Hsu; Tien-Ling Liao; An-Chen Feng; Nei-Min Chu; Shu-Huei Kao
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

9.  Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.

Authors:  Xingqun Ma; Yanwen Yao; Dongmei Yuan; Hongbing Liu; Shouju Wang; Changsheng Zhou; Yong Song
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis.

Authors:  Huan Xia; Xiao-Juan Wang; Qiong Zhou; Huan-Zhong Shi; Zhao-Hui Tong
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.